Interferons as biomarkers and effectors: lessons learned from animal models

Cassandra M Berry1, Paul J Hertzog, Niamh E Mangan

  • 1Centre for Innate Immunity & Infectious Diseases, Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia. c.berry@murdoch.edu.au

Biomarkers in Medicine
|March 28, 2012
PubMed
Summary

Interferons (IFNs) and their stimulated genes (ISGs) can serve as biomarkers for disease outcomes in infectious and inflammatory conditions. Animal models reveal how IFN responses inform disease pathogenesis and therapeutic development.